Invention Grant
- Patent Title: Compounds
- Patent Title (中): 化合物
-
Application No.: US13125841Application Date: 2009-07-28
-
Publication No.: US08853420B2Publication Date: 2014-10-07
- Inventor: Matthias Treu , Thomas Karner , Ulrich Reiser
- Applicant: Matthias Treu , Thomas Karner , Ulrich Reiser
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Mary-Ellen M. Devlin
- Priority: EP08161381 20080729
- International Application: PCT/EP2009/059770 WO 20090728
- International Announcement: WO2010/012747 WO 20100204
- Main IPC: C07D209/34
- IPC: C07D209/34 ; C07D401/10 ; C07D403/10 ; C07D403/14 ; C07D413/14 ; C07D405/10 ; C07D405/12 ; C07D403/12 ; C07D405/06 ; C07D405/04 ; C07D401/06 ; C07D403/04 ; C07D487/10 ; C07D405/14 ; C07D401/14 ; C07D401/04 ; C07D471/08
Abstract:
The present invention encompasses compounds of general formula (1), wherein R1 to R4 are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties.
Public/Granted literature
- US20110263565A1 COMPOUNDS Public/Granted day:2011-10-27
Information query
